NewsBenzingaAstrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est Benzinga 2026.09.23 13:34 (GMT+0) Open on Benzinga Other news EYPT Stock Layoffs: What to Know About the Latest EyePoint Job Cuts Stocks Settle Higher as Chipmakers and AI-Infrastructure Stocks Rebound JP Morgan Maintains Overweight on First Solar, Lowers Price Target to $252 Karooooo Q2 Adj. EPS $0.57, Inline, Sales $100.292M Beat $97.720M Estimate Karooooo Affirms FY2027 GAAP EPS Guidance of $2.35-$2.44 vs $2.41 Est Lear Appoints Jared Fedele CFO, Effective March 1, 2027, Succeeding Jason Cardew
